StonvexLoading…
StonvexStonvexStonvexCore line items from ESS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.31M | $9.38M | $7.08M | $4.72M |
Operating Income | $155.19M | $899.32M | $747.18M | $536.78M |
Net Income | $112.21M | $702.77M | $617.03M | $444.30M |
EPS (Diluted) | $1.65 | $10.40 | $9.15 | $6.59 |
Total Assets | $13.10B | $13.16B | $13.15B | $13.18B |
Total Liabilities | $7.47B | $7.42B | $7.32B | $7.34B |
Cash & Equivalents | $38.01M | $76.24M | $65.96M | $58.68M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 64.31M | 64.44M | 64.40M | 64.40M |